Michael D. West

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Dr. Michael D. West is CEO of Biotime, of Alameda, California, a company engaged in stem cell research and development, development of low temperature medicine (ice cold suspended animation technologies), and development of artificial blood plasma solutions for the treatment for blood loss due to trauma and elective surgery. He is also Adjunct Professor of Bioengineering at the University of California, Berkeley. He was Chairman of the Board, Chief Scientific Officer, and former CEO of Advanced Cell Technology Corporation, which specializes in stem cell research.[1][2][3][4]

Dr. West also founded Geron Corporation, a biotechnology company based in Menlo Park, California, and served as its Director and Senior Executive Officer from 1990 to 1998. The company was incorporated in 1990 and began doing business in 1992. Geron Corporation focuses on creating drugs based on telomere and stem cell research.[5]

West has been featured in numerous news media reports concerning somatic cell nuclear transfer technology, and has testified before the U.S. Congress on this subject[6]. His 2003 book The Immortal Cell tells the story of his personal struggles in researching regenerative medicine and the problem of human aging.

Contents

[edit] Bibliography

[edit] Books

  • Michael D. West, The Immortal Cell, Doubleday (2003) ISBN 978-0385509282
  • Gregory M. Fahy, Michael D. West, L. Stephen Coles, Steven B. Harris, The Future of Aging: Pathways to Human Life Extension, Springer (2010) ISBN 978-9048139989

[edit] References

[edit] See also

[edit] External links


Personal tools
Namespaces
Variants
Actions
Navigation
Interaction
Toolbox
Print/export